Latest debt-to-equity ratio
Oramed Pharmaceuticals Debt-to-equity ratio
Direct answer
Oramed Pharmaceuticals's debt-to-equity ratio is 0.23%.
The verified market snapshot reports 0.23%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.
Get free Oramed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.23%
Explore related company data
View Oramed Pharmaceuticals's market capitalizationView Oramed Pharmaceuticals's p/e ratioView Oramed Pharmaceuticals's price-to-book ratioView Oramed Pharmaceuticals's return on equityView Oramed Pharmaceuticals's dividend yieldView Oramed Pharmaceuticals's 52-week price rangeView Oramed Pharmaceuticals's profit marginView all Oramed Pharmaceuticals key metricsReturn to Oramed Pharmaceuticals profile